Ecopipam in Tourette's Disorder |
Welcome
Thank you very much for your interest in our study. We are attempting to assess the efficacy of Ecopipam vs. placebo for the treatment of Tourette's Disorder in children (ages 6 and older), adolescents, and adults. The study is conducted under Dr. Jon Grant at the University of Chicago and involves screening visits and then approximately 15 in-person visits over a period of 30 weeks (7 months). Participants will be compensated for their time and travel. The information you provide here will be kept confidential and will not be used for purposes other than seeing if you or your child are eligible to participate in the study.
If you have additional questions, please call 773-702-5523.